J&J in discussions to buy Ollin Biosciences for up to $3.4B - report

Jeff Schear/Getty Images Entertainment
Johnson & Johnson (JNJ) is in talks to acquire privately held biotech company Ollin Biosciences for up to $3.4B, with a deal potentially being announced as soon as Monday, the Financial Times reported, citing people familiar with the matter.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.